(Q41973331)

14 October 2017

Cancer-associated tumour markers CA 19-9 and CA-50 in patients with pancreatic cancer with special reference to the Lewis blood cell status (English)

1 reference

14 October 2017

1 reference

Masson P

1

1 reference

14 October 2017

Pålsson B

series ordinal

2

1 reference

14 October 2017

Andrén-Sandberg A

series ordinal

3

1 reference

14 October 2017

language of work or name

English

0 references

publication date

1 July 1990

1 reference

British Journal of Cancer

14 October 2017

1 reference

14 October 2017

62

1 reference

14 October 2017

1

1 reference

14 October 2017

118-121

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1990.241

14 October 2017

0 references

cites work

Blood-group substances

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971719

Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971719

CA-50 in patients with pancreatic disease--an evaluation of three different laboratory techniques.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971719

Monoclonal antibodies raised against NeuAc alpha 2-6neolactotetraosylceramide detect carcinoma-associated gangliosides.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971719

Colorectal carcinoma antigens detected by hybridoma antibodies

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971719

The presence of CA19-9 in serum and saliva from Lewis blood-group negative cancer patients.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971719

A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.

3 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971719

Comparison of CA 50 and CA 19-9 tumor markers in benign and malignant diseases of the upper gastrointestinal tract

18 August 2018

1 reference

12 December 2020

[CA-19-9, CA50 and CEA in pancreatic and gastrointestinal tumors. Comparative studies]

1 reference

12 December 2020

Expression of blood group-related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA 19-9 in pancreatic cancer cells in comparison with the patient's blood group type

1 reference

12 December 2020

Tissue expression of the cancer-associated antigens CA 19-9 and CA-50 in chronic pancreatitis and pancreatic carcinoma

1 reference

12 December 2020

Observations on the human group system Lewis

1 reference

12 December 2020

Possible Genetical Pathways for the Biosynthesis of Blood Group Mucopolysaccharides

1 reference

12 December 2020

In vitro transformation of the Lewis blood groups of erythrocytes

1 reference

12 December 2020

Molecular and Genetic Aspects of Human Blood-group Leb Specificity

1 reference

12 December 2020

Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides

1 reference

12 December 2020

Chemical structure of carcinoma ganglioside antigens defined by monoclonal antibody C-50 and some allied gangliosides of human pancreatic adenocarcinoma

1 reference

12 December 2020

Lea-active heptaglycosylceramide, a hybrid of type 1 and type 2 chain, and the pattern of glycolipids with Lea, Leb, X (Lex), and Y (Ley) determinants in human blood cell membranes (ghosts). Evidence that type 2 chain can elongate repetitively but t

1 reference

12 December 2020

Serum CA 50 as a tumor marker in pancreatic cancer: a comparison with CA 19-9

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1990.241

1 reference

14 October 2017

1 reference

14 October 2017

PubMed publication ID

2390470

1 reference